As drug companies join social networking sites to promote their brands, they’ve been avoiding communicating sensitive information about specific products and potential adverse events. Until the FDA implements guidelines for advertising in the new social media, pharma will probably continue to play it safe as it wades into the twittersphere.
You are here
P&T® Journal contents for July 2010
How U.S. Hospitals and the Federal Government Are Working to Reduce Adverse Events
Although our nation’s blood supply has become safer and transfusion-associated risks have decreased, preventable errors still occur. Typing blood and cross-matching are complex procedures, but bar coding and radiofrequency identification are enhancing the safety of the blood supply at various hospitals.
Despite treatment guidelines indicating that inhaled corticosteroid (ICS) therapy is effective and safe for mild-to-moderate persistent asthma, ICS monotherapy continues to be underused. Present prescribing patterns result in higher drug costs and may expose patients to safety risks.
Etiology, Diagnosis, and Treatment
Epilepsy affects more than 3 million people in the U.S. and about 50 million people worldwide. Because of the myriad types of seizures, choosing the right medication for each patient is essential. This article reviews approved and forthcoming agents and includes a comprehensive appendix showing warnings, adverse events, and contraindications.